A health care worker in New York prepares a Moderna vaccine. Michael M. Santiago/Getty ImagesEuropean regulators on April 21 cleared a combination vaccine made by Moderna that targets COVID-19 and influenza.Moderna’s messenger ribonucleic acid (mRNA) vaccine, mCombriax, is the first authorized combination flu–COVID shot after receiving clearance from the European Commission for individuals aged 50 and older.
Ohio State Agrees to $2.1 Million Federal Settlement Over Undisclosed China Research Ties
Ohio State University has agreed to pay $2.1 million to resolve federal...
Chinese Scientists Flagged Glacial Flood Danger One Year Before Nepal Catastrophe
More than a year before the catastrophic flash flood devastated the China–Nepal...
Chinas Humanoid Robot Companies Face Reality Check
China is showcasing humanoid robots as symbols of its technological ambitions. However,...
Iceland Focuses on Security Partnerships After Voters Reject Opening EU Membership Talks
Icelandic Minister for Foreign Affairs Thorgerdur Katrin Gunnarsdottir attends a press conference...
